Yantacaw Capital
Venture fund · from SEC filings

Orbimed Asia Partners V, LP

OrbiMed · adviser of record: Orbimed Advisors LLC · 2021 vintage

Orbimed Asia Partners V, LP is a 2021 venture fund managed by OrbiMed, with $652mm raised (Form D, amount sold). It reported $948mm in gross assets at year-end 2025, 1.45x its size, its highest reported value.

Latest value held
$948mm year-end 2025
Peak
$948mm year-end 2025
Fund size
$652mm Form D, amount sold
Held vs. size
1.45x peak 1.45x

Value held by year-end

$200mm$400mm$600mm$800mm$1bn20212022202320242025

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2025$948mm1.45x+29% over 2 yrs
2023$733mm1.12x+47%
2022$497mm0.76x+0%
2021$497mm0.76x–

Other funds from OrbiMed

All OrbiMed funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-1599250392. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.